🟢 Edesa Biotech is trading 14.86% up in pre-market

Edesa Biotech is trading at $3.17, up 14.86% in pre-market, with no clear catalyst identified.

• No company-specific announcement dated October 23 was found in the available search results.
• The latest identified company news was October 15 FDA clearance for a Phase 2 vitiligo study; it is prior context, not a confirmed reason for the rise.
• The broader market indicators provided are lower and do not explain the upward move.